NASDAQ:PMN | Free Cash Flow | ProMIS Neurosciences Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2021-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$12.38M
2025-12-31-$9.28M
2025-03-31-$4.93M
2024-12-31-$8.72M
2024-03-31-$10.29M
2023-12-31-$3.76M
2023-03-31-$2.56M
2022-12-31-$4.55M-$43.00-$4.55M
2022-03-31-$3.37M$2,057.00-$3.37M
2021-12-31-$4.05M$4,857.00-$4.05M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$28.12M
2024-12-31-$27.18M
2023-12-31-$10.84M
2022-12-31-$17.03M$1,981.00-$17.04M
2021-12-31-$9.31M$6,044.00-$9.31M